openPR Logo
Press release

Preventive Vaccine Market Growth, Trends, Analysis and Forecast - 2025

07-25-2020 02:23 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

Preventive Vaccine Market

Preventive Vaccine Market

The global preventive vaccine market is estimated to grow at a CAGR of nearly 9.0% during the forecast period. Before the COVID-19, the major dynamic moving the market include rising per capita healthcare expenditure of the emerging economies, and increasing awareness related to the vaccine. With the increasing cases of COVID-19, the need to develop preventive vaccines increased all across the growth. A disruption in revenue of segments will be also witnessed during the forecast period. For instance, generally, most of the revenue is generated by pediatric vaccines however for the next couple of years it will be shift to adult vaccines.

Get Sample Copy of Preventive Vaccine Market at: https://www.omrglobal.com/request-sample/preventive-vaccine-market

The major players operating in the market include Sanofi SA, GlaxoSmithKline PLC, CSL Ltd., Merck & Co., Inc., Pfizer Inc., Gilead Sciences, Inc., Astellas Pharma Inc., AstraZeneca plc, China National Biotec Group Company Ltd., Emergent BioSolutions Inc., Mitsubishi Tanabe Pharma Corp., Teva Pharmaceutical Industries Ltd.

Government organizations are funding and collaborating with private players to speed up vaccine development for COVID-19. For instance, the US Biomedical Advanced Research and Development Authority (BARDA) has announced to donate $483 million to Moderna Inc., a Biotech company for the development of the COVID-19 vaccine. The German government has announced to spend $812 million to develop and distribute the COVID-19 vaccine. Two-third of $812 million will be for vaccine development and the rest of the money for developing production capacity.

Generally, to develop a vaccine 10 to 15 years are required however the vaccine manufacturing companies are trying to reduce this time to 12 to 18 months. On 13th April 2020, the World Health Organization announced that there are around 70 coronavirus vaccines under development all across the globe. Out of this, three candidates already are being tested in human trials. Some of the major companies which are working significantly for the vaccine development include Pfizer Inc., GSK plc, Inovio Pharmaceuticals, Johnson & Johnson, Sanofi, and others.

For More Information, get A full report of Preventive Vaccine Market is available at: https://www.omrglobal.com/industry-reports/preventive-vaccine-market

In March 2020, Pfizer Inc. partnered with BioNtech SE for the development of mRNA based COVID-19 vaccine candidate BNT-162 of BioNtech SE. The company has entered the clinical stage in Germany and the US in May 2020. In April, two major drug companies Sanofi SA and GSK plc. collaborated to develop the COVID-19 vaccine. The candidate vaccine is expected to enter clinical trial by the second half of 2020 and if approved by the government it will be available to the market by the second half of 2021.

Inovio Pharmaceuticals is one of the first companies to work on the COVID-19 vaccine. In April 2020, the company completed the first dose of vaccine in 40 healthy volunteers in the phase-I clinical stage with INO-4800 in the US. The company will complete the second round of dosing by the end of May 2020. Several other companies such as Novavax, Heat Biologics, Glenmark, Vaxart, Vir Biotechnology are working in the COVID-19 vaccine.

Global Preventive Vaccine Market- Segmentation

By Vaccine Type

Live-attenuated vaccines
Inactivated vaccines
Subunit, recombinant, polysaccharide, and conjugate vaccines
Toxoid vaccines
Other (DNA Vaccines And Recombinant Vector Vaccines)

By Patient

Pediatric
Adults
Global Preventive Vaccine Market– Segment by Region

North America

US
Canada
Europe

Germany
UK
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Latin America
The Middle East and Africa


For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/preventive-vaccine-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preventive Vaccine Market Growth, Trends, Analysis and Forecast - 2025 here

News-ID: 2096741 • Views:

More Releases from Orion Market Research

Biocatalysis and Biocatalysts Market Overview: Growth, Share, Value, Size, and Scope
Biocatalysis and Biocatalysts Market Overview: Growth, Share, Value, Size, and S …
In 2023, the Biocatalysis and Biocatalysts Market was estimated at approximately USD 3.5 billion, and by 2033, it is expected to reach around USD 7.2 billion, implying a CAGR of about 7.5% from 2024 to 2033. Biocatalysis and Biocatalysts Market Overview The Biocatalysis and Biocatalysts Market is experiencing strong growth as industries increasingly adopt enzyme-driven and whole-cell catalysis for sustainable and efficient chemical processes. This market spans applications in pharmaceuticals, food and
Automotive Coolant Market: Emerging Trends and Growth Forecast to 2033
Automotive Coolant Market: Emerging Trends and Growth Forecast to 2033
In 2023, the Automotive Coolant Market was valued at approximately USD 7.59 billion, and by 2033, it is projected to reach approximately USD 8.31 billion, reflecting a CAGR of about 4.9% from 2024 to 2033. Automotive Coolant Market Overview The Automotive Coolant Market is expanding steadily, driven by increasing global vehicle production, rising demand for high-performance engines, and growing emphasis on efficient thermal management systems. Automotive coolants are essential for regulating engine
Anti Osteoporosis Therapy and Fracture Healing Market - Industry Trends and Forecast to 2033
Anti Osteoporosis Therapy and Fracture Healing Market - Industry Trends and Fore …
In 2023, the Anti-Osteoporosis Therapy and Fracture Healing Market was valued at about USD 14.05 billion, and by 2033, it is anticipated to grow to approximately USD 22.43 billion, with a CAGR of around 4.8% from 2024 to 2033. Anti Osteoporosis Therapy and Fracture Healing Market Overview The Anti-Osteoporosis Therapy and Fracture Healing Market is experiencing steady expansion, driven by a rising prevalence of osteoporosis and age-related fractures globally. This market encompasses
Photographic Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Photographic Service Market Size Analysis, Competitive Insights, Leading Players …
In 2023, the global Photographic Service Market was approximately USD 43.1 billion, and by 2033, it is projected to reach approximately USD 82-85 billion, reflecting a compound annual growth rate of around 4.4% from 2024 to 2033. Photographic Service Market Overview The Photographic Services Market continues to expand steadily, anchored by robust demand for visual storytelling across social media, e-commerce, personal milestones, and branding efforts. The industry spans a broad service spectrum-from

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion